Benitec Biopharma Ltd ADR (BNTC) — Working Capital to Net Assets Ratio
Benitec Biopharma Ltd ADR (BNTC) has a Working Capital to Net Assets ratio of 99.7% as of December 2025. Working capital of $186.79 Million (current assets of $189.59 Million minus current liabilities of $2.80 Million) is measured against net assets of $187.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Benitec Biopharma Ltd ADR balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Benitec Biopharma Ltd ADR Working Capital to Net Assets (2013–2025)
This chart shows how Benitec Biopharma Ltd ADR's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting working capital of $186.79 Million against net assets of $187.36 Million USD. Check BNTC tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Benitec Biopharma Ltd ADR (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Benitec Biopharma Ltd ADR from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BNTC stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.4% | $96.72 Million | $97.30 Million | $98.52 Million | $1.80 Million | ▲ +0.5 pp |
| 2024 | 98.9% | $46.75 Million | $47.25 Million | $51.67 Million | $4.92 Million | ▲ +222.2 pp |
| 2023 | -123.3% | $-249.00K | $202.00K | $3.73 Million | $3.98 Million | ▼ -202.7 pp |
| 2022 | 79.4% | $2.29 Million | $2.88 Million | $4.82 Million | $2.53 Million | ▼ -16.8 pp |
| 2021 | 96.1% | $19.24 Million | $20.01 Million | $20.61 Million | $1.37 Million | ▲ +1.7 pp |
| 2020 | 94.5% | $9.67 Million | $10.24 Million | $10.81 Million | $1.14 Million | ▼ -2.6 pp |
| 2019 | 97.1% | $16.09 Million | $16.57 Million | $18.73 Million | $2.64 Million | ▼ -0.8 pp |
| 2018 | 97.9% | $13.48 Million | $13.77 Million | $15.35 Million | $1.87 Million | ▲ +0.1 pp |
| 2017 | 97.8% | $16.17 Million | $16.53 Million | $17.03 Million | $864.51K | ▲ +0.4 pp |
| 2016 | 97.4% | $13.70 Million | $14.07 Million | $14.48 Million | $772.92K | ▼ -0.7 pp |
| 2015 | 98.1% | $17.96 Million | $18.31 Million | $19.22 Million | $1.26 Million | ▲ +0.0 pp |
| 2014 | 98.1% | $22.05 Million | $22.48 Million | $23.60 Million | $1.55 Million | ▼ -1.8 pp |
| 2013 | 99.9% | $30.57 Million | $30.61 Million | $31.44 Million | $871.53K | — |